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In	 some	 parts	 of	 western	Africa,	 Ebola	 treatment	 centers	
(ETCs)	 have	 reached	 capacity.	Unless	 capacity	 is	 rapidly	
scaled	 up,	 the	 chance	 to	 avoid	 a	 generalized	 Ebola	 epi-
demic	 will	 soon	 diminish.	 The	World	 Health	 Organization	
and	partners	are	considering	additional	Ebola	patient	care	
options,	 including	 community	 care	 centers	 (CCCs),	 small,	
lightly	staffed	units	that	could	be	used	to	isolate	patients	out-
side	the	home	and	get	them	into	care	sooner	than	otherwise	
possible.	 Using	 a	 transmission	 model,	 we	 evaluated	 the	
benefits	and	risks	of	introducing	CCCs	into	Sierra	Leone’s	
Western	Area,	where	most	ETCs	are	at	capacity.	We	found	
that	use	of	CCCs	could	lead	to	a	decline	in	cases,	even	if	
virus	 transmission	 occurs	 between	CCC	 patients	 and	 the	
community.	However,	 to	prevent	CCC	amplification	of	 the	
epidemic,	the	risk	of	Ebola	virus–negative	persons	being	ex-
posed	to	virus	within	CCCs	would	have	to	be	offset	by	a	re-
duction	in	community	transmission	resulting	from	CCC	use.
The current epidemic of Ebola virus disease in western Africa has resulted in thousands of cases during 2014 
(1). To date, Ebola treatment centers (ETCs) have been used 
to isolate patients and provide clinical care. These facilities 
typically have large capacity (some have >100 beds) and 
function under high levels of infection control. However, 
in Sierra Leone, ETCs have reached capacity, and patients 
are being turned away (1). The reproduction number (de-
fined as the average number of secondary cases generated 
by a typical infectious person) has been >1 in Sierra Leone, 
leading to growth in the number of cases reported each 
week (2–4). As a result, there is an urgent need to rapidly 
scale up treatment and isolation facilities. Delays in imple-
mentation will result in falling further behind the epidemic 
curve and in an even greater need for patient care facilities.
ETCs are complex facilities that require a substantial 
number of staff and time to set up; thus, the World Health 
Organization and other partners are looking at additional 
care options to supplement existing ETCs. One approach 
is the use of Ebola community care centers (CCCs), which 
would represent a possible change in operational approach 
(5–7). As envisioned in the World Health Organization 
approach, CCCs would be small units with 3–5 beds and 
would be staffed by a small group of health care workers. 
The main objective would be to isolate patients outside the 
home and, hence, reduce the movement and contacts of in-
fectious persons within the community. CCCs are designed 
to engage the community and to increase the acceptance 
of isolation. Care for patients in CCCs would be provided 
primarily by a caregiver who would be given personal pro-
tective equipment (PPE) and basic patient care training. 
Patients would be free to leave the unit while awaiting test 
results. The specific utilization of CCCs would vary, de-
pending on local context, and units would form part of a 
package of interventions, including monitoring of commu-
nity contacts and burials within the community.
CCCs would be easier to set up than ETCs because 
they would be lightly staffed and could be made from local 
materials or even tents. Thus, CCCs have the potential to 
more rapidly begin treating patients. At present in Sierra 
Leone, the average time from symptom onset to hospital-
ization for Ebola virus disease patients is 4.6 days, which 
means patients remain in the community until the late stage 
of the disease (4). However, the use of CCCs has potential 
risks: the number of cases could be amplified if Ebola vi-
rus–negative patients in CCC assessment areas are exposed 
to infectious persons before admission, and virus could be 
transmitted between patients and caregivers or others in 
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the community if virus containment within the CCC is not 
perfect. Given the urgent need for new operational solu-
tions for Ebola patient care, it is critical to assess the condi-
tions under which CCCs might exacerbate or mitigate the 
epidemic and to compare the scale-up of CCCs with the 
expansion of ETCs or home care.
We used an Ebola virus transmission model to evalu-
ate the relative benefits and risks of introducing CCCs in a 
situation similar to that in Western Area, an administrative 
division of Sierra Leone. Western Area has exhibited con-
sistent exponential growth in reported cases, and ETCs in 
the area are at capacity (1). Expert elicitation was used to 
estimate plausible values for key model parameters; these 
values were compared with simulation results to establish 
whether CCCs could be beneficial. We also estimated how 
many CCC beds, either alone or in combination with addi-
tional ETC beds, would be required to potentially turn over 
the epidemic (i.e., reduce the reproduction number below 
the critical threshold of 1).
Methods
Because precise medical and operational details of CCCs 
are still under discussion, we focused on the implications 
of CCC introduction under a set of general assumptions. 
We modeled Ebola transmission by using a modified sus-
ceptible-exposed-infectious-resolved framework (8–10). In 
the model, persons were initially susceptible to the virus; 
upon infection, patients moved into a latent state for an av-
erage of 9.4 days (4) and then became symptomatic and 
infectious for an average of 9.5 days (4) before the disease 
was resolved (through either recovery or death and buri-
al) and the patient no longer contributed to transmission. 
The model accounted for changes in ETC capacity to date 
(details available at https://drive.google.com/file/d/0B_
BzCqSK1DZaYnRoeWtHOTU2TVk/). 
First, we used the model to generate epidemiologic 
forecasts for Western Area and to establish a baseline sce-
nario for the level of infection if no additional interven-
tions were introduced. We fitted the model to the number 
of weekly reported Ebola virus disease cases in Western 
Area during August 16–November 31, 2014 (1). We es-
timated that in Western Area the basic reproduction num-
ber (defined as the average number of secondary cases 
generated by a typical infectious person in the absence of 
control measures) was 1.94 (95% credible interval [CrI] 
1.86–1.98) and that there would be 1,060 exposed persons 
(95% CrI 800–1,420) and 650 symptomatic persons (95% 
CrI 460–910) in the community on December 1, 2014.
To model the introduction of CCCs, we assumed that 
Ebola virus–susceptible persons could also become infected 
with other febrile diseases that have Ebola virus disease–like 
symptoms, which we assumed had symptoms that lasted an 
average of 7 days. Thus, 2 types of symptomatic persons were 
included in our simulation model: Ebola virus–positive and 
Ebola virus–negative patients (Figure 1; https://drive.google.
com/file/d/0B_BzCqSK1DZaYnRoeWtHOTU2TVk/). 
In the model, Ebola virus–positive and –negative patients 
took an average of 4.6 days (4) after the onset of symptoms 
before attending an ETC. The probability that a patient 
was admitted to an ETC depended on the number of cur-
rently available beds. Well-managed ETCs operate strict 
patient isolation, careful use of PPE, and safe burial pro-
cedures (11,12), so we assumed that no virus transmission 
occurred between Ebola virus–infected patients and com-
munity members once patients were admitted to an ETC. If 
suspected case-patients were admitted to ETCs and subse-
quently found to be negative for Ebola virus, they returned 
to the community; we assumed there was no risk of Ebola 
virus–negative patients becoming infected while waiting for 
test results.
We also included CCCs in the model. We assumed that 
for patients visiting local CCCs, the time between symptom 
onset and CCC visit was shorter than that for patients visit-
ing the larger and more distant ETCs; in the main analysis, 
we assumed that the average time from symptom onset to 
CCC attendance was 3 days. If CCCs were full, then pa-
tients attended ETCs instead. If ETCs were full, patients re-
mained in the community. We assumed there was a possi-
bility for some transmission of virus from CCC patients to 
community members (either directly, through caregivers, 
Figure 1.	Structure	of	transmission	model	used	to	evaluate	the	
benefits	and	risks	of	introducing	CCCs	into	Western	Area,	Sierra	
Leone.	Persons	start	off	being	susceptible	to	infection	(S).	Upon	
infection	with	Ebola	virus,	they	enter	an	incubation	period	(E),	
and	at	symptom	onset,	they	become	infectious	in	the	community	
(I+).	After	this	point,	infected	persons	seek	health	care	in	CCCs	
or	ETCs;	if	centers	are	full,	the	infectious	persons	remain	in	the	
community	until	the	infection	is	resolved	(R)	(i.e.,	the	patients	
have	recovered	from	the	disease	or	are	dead	and	buried).	
Patients	admitted	to	ETCs	and	CCCs	also	move	into	the	resolved	
compartment	(R).	We	also	assume	that	Ebola	virus–susceptible	
persons	could	also	become	infected	with	other	febrile	diseases	
that	have	Ebola	virus	disease–like	symptoms	(I–).	These	Ebola	
virus–negative	patients	also	seek	health	care;	if	centers	are	
full,	the	patients	return	to	the	susceptible	compartment	(S)	as	
symptoms	wane.	We	assume	the	latent	period	is	9.4	days,	the	
average	time	from	symptom	onset	to	CCC	attendance	is	3	days,	
and	the	average	interval	from	symptom	onset	to	ETC	attendance	
is	4.6	days.	CCCs,	Ebola	community	care	centers;	ETCs,	Ebola	
treatment	centers.
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or during burial); we did not assume any transmission of 
virus from ETC patients. There was also a chance that 
Ebola virus–negative patients would be exposed to Ebola 
virus while waiting for test results. We assumed that 50% 
of symptomatic patients who attended CCCs/ETCs were 
Ebola virus–positive; on the basis of the number of Ebola 
virus disease cases and noncases reported in Sierra Leone, 
this percentage is plausible (1,13,14).
Two other parameters, besides the shorter time be-
tween onset of symptoms and attendance at a center, make 
CCCs potentially different from ETCs in the model: 1) the 
probability that Ebola virus–negative patients would be ex-
posed to Ebola virus while waiting for test results in CCCs 
and 2) the reduction in virus transmission from infectious 
patients to the community as a result of the patient being 
isolated in a CCC. If the CCC model had a 100% reduction 
in transmission and 0% chance that Ebola virus–negative 
patients would be exposed virus, it was equivalent to the 
ETC set-up in the model, except that there would be a re-
duced time from symptom onset to CCC attendance.
Results
We first considered the potential level of infection in the com-
munity during December 2014 based on our estimates for 
Western Area. With 259 ETC beds available (1,14–16), our 
model suggests that ETCs would be at capacity in mid-De-
cember and the number of cases would rise over the follow-
ing weeks (Figure 2, panel A). We also considered the pos-
sibility that a proposed additional 500 ETC beds (15) would 
be introduced on December 15, 2014 (Figure 2, panel B). Our 
forecast suggested that the addition of these beds would cause 
the growth in number of cases to slow in the following weeks, 
but the change would not turn over the epidemic.
To assess what reduction in transmission and in risk 
of Ebola virus–negative patient exposure to virus would be 
required for 500 CCC beds to be beneficial, we varied 2 
key parameters and, after 30 days, compared model out-
puts with those for the baseline scenario (Figure 3, panel 
A). If there is a high probability that Ebola virus–negative 
patients will be exposed but only a small reduction in trans-
mission, CCCs could act as incubators and generate more 
cases than the baseline scenario with 259 ETC beds only.
The CCC approach has not been fully tested in the field, 
so we conducted an elicitation of 6 expert opinions to ob-
tain estimates for the median and interquartile range (IQR) 
for reduction in transmission as a result of patients being 
in CCCs and for the probability of exposing Ebola virus–
negative patients to infectious patients (details at https://
drive.google.com/file/d/0B_BzCqSK1DZaYnRoeW-
tHOTU2TVk/). The distribution for the group opinion for 
reduction in transmission while in a CCC had a median of 
63% (IQR 41%–81%). The distribution for the probabil-
ity of exposure had a median of 0.09 (IQR 0.01–0.36). 
When compared with model results, these estimates were 
within the region of parameter space in which CCCs would 
be beneficial (see Figure 3 at https://drive.google.com/file/
d/0B_BzCqSK1DZaYnRoeWtHOTU2TVk/).
Figure 2.	Model	fits	and	forecasts	used	to	evaluate	the	benefits	
and	risks	of	introducing	Ebola	community	care	centers	into	
Western	Area,	Sierra	Leone.	A)	Reported	cases	over	time.	
Black	points	show	reported	incidence	data.	B)	No.	patients	in	
ETC	beds.	Blue	lines	to	the	left	of	the	dashed	vertical	divides	
show	the	median	estimate;	blues	line	to	the	right	of	the	dashed	
vertical	divides	show	forecast	with	no	change	in	number	of	
ETC	beds;	green	lines	show	forecast	if	500	ETC	beds	are	
introduced	on	December	15,	2014.	Shaded	areas	represent	
95%	credible	interval,	which	reflects	uncertainty	about	reporting	
and	model	parameters;	darker	shading	indicates	overlap	
between	2	forecasts.	Estimates	were	scaled	depending	on	the	
number	of	daily	situation	reports	issued	by	the	Sierra	Leone	
Ministry	of	Health	and	Sanitation	each	week	(see	https://drive.
google.com/file/d/0B_BzCqSK1DZaYnRoeWtHOTU2TVk/).	
ETC,	Ebola	treatment	center.
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To confirm that 63% was a plausible value for reduction 
in transmission, we used the following theoretical argument. 
In the model, the basic reproduction number, R0, was near 2, 
the time from onset to outcome was 9.5 days on average, and 
patients took an average of 3 days after onset of symptoms 
to attend CCCs. If infected persons did not enter an available 
CCC and instead remained in the community for the next 
6.5 days, they would generate an average of 1.4 secondary 
cases (because 2 × 6.5/9.5 = 1.4). Even if Ebola patients had 
a 50% probability of infecting their sole caregiver, it meant 
they would, on average, generate 0.5 secondary cases while 
in a CCC. The relative reduction in cases as a result of being 
in a CCC would therefore be (1.4 –0.5)/1.4 = 64%. If each 
case-patient generated an average of 0.25 cases while in a 
CCC, the expected reduction would be ≈80%.
To elucidate the potential benefits and risks of CCC 
introduction, we considered 2 specific examples. If CCCs 
reduced virus transmission from Ebola virus–infected pa-
tients to the community by 75% once the patient was ad-
mitted and if Ebola virus–negative patients have a 25% 
probability of exposure while waiting for test results, then 
the introduction of 500 CCC beds would slow virus trans-
mission (Figure 3, panel B). However, if CCCs only re-
duced transmission by 25% and Ebola virus–negative pa-
tients have a 50% probability of exposure to Ebola virus, 
the introduction of 500 CCC beds could lead to a rise in the 
number of cases within the community (Figure 3, panel B).
We also assessed how many CCC beds would be re-
quired to stop the exponential increase in cases and turn 
over the epidemic (i.e., reduce the reproduction number 
of the infection, R, to <1). A larger number of beds would 
be required if the reduction in transmission was smaller 
(Figure 4, panel A). The requirement was also larger if Eb-
ola virus–negative patients were more likely to be exposed 
to virus, patients took longer to attend CCCs, or there were 
more Ebola virus–negative patients (see figures 4 and 5 at 
https://drive.google.com/file/d/0B_BzCqSK1DZaYnRoe 
WtHOTU2TVk/). The large number of infected persons on 
December 1, 2014, meant that the number of cases still rose 
in the model (Figure 2), suggesting additional interventions 
would be required to control the epidemic. Therefore we as-
sessed a combination of the 2 health care approaches, with 
additional ETC beds, CCC beds, or both introduced on De-
cember 15, 2014 (Figure 4, panel B). Because CCCs reduce 
the time from symptom onset to attendance at a health care 
center, our results suggest it would be possible to turn over 
the epidemic in Western Area with a sufficient number of 
CCC beds, either as a standalone strategy or in combination 
with additional ETCs.
Discussion
We used a transmission model to evaluate the potential ef-
fects of the introduction of Ebola CCCs in Western Area, 
Figure 3.	Factors	influencing	reduction	or	amplification	of	Ebola	
virus	infection	in	the	community	if	500	CCC	beds	were	introduced	
in	Western	Area,	Sierra	Leone,	on	December	15,	2014.	A)	Change	
in	infection	compared	with	baseline	scenario	(259	Ebola	treatment	
center	beds)	between	December	1,	2014,	and	February	1,	2015,	
for	a	range	of	values	for	reduction	in	transmission	and	probability	
of	exposure	to	virus.	Median	parameter	estimates	for	Western	
Area	were	used	(Table).	B)	Change	in	infection	over	time.	Black	
line,	baseline	scenario.	Blue	line,	500	CCC	beds	with	transmission	
reduced	by	75%	(blue	line	in	A),	and	Ebola	virus–negative	patients	
have	25%	probability	of	exposure	to	virus.	Red	line,	500	CCC	
beds	with	transmission	reduced	by	25%	(red	line	in	A),	and	Ebola	
virus–negative	patients	have	50%	probability	of	exposure	to	virus.	
Shaded	areas	show	95%	bootstrapped	credible	intervals	generated	
from	1,000	simulations	with	parameters	sampled	from	posterior	
estimates.	We	assumed	that	time	from	symptom	onset	to	CCC	
attendance	was	3	days	and	that	50%	of	symptomatic	patients	were	
Ebola	virus–positive.	CCC,	Ebola	community	care	center.
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Sierra Leone. Our results show that CCCs could reduce the 
number of Ebola virus disease cases in the community if 
1) the probability for Ebola virus–negative patients being 
exposed to the virus is low and 2) there is reduction in virus 
transmission as a result of infected patients being in CCCs. 
The introduction of CCCs could potentially turn over the 
epidemic (i.e., reduce the reproduction number, R, below 
the critical threshold of 1) if the time from symptom onset 
to CCC attendance is <3 days. Assuming that CCCs open 
in mid-December, ensuring epidemic turnover would re-
quire a large number of CCC beds (potentially at least 500 
for Western Area). In addition to reducing the time from 
symptom onset to attendance at a treatment facility, a large 
number of CCCs would have the added benefit of reduc-
ing the time from symptom onset to admission because 
infected patients would not have to wait for ETC beds to 
become available.
Our analysis does have limitations. One of those limi-
tations is that we used an illustrative scenario for Western 
Area based on current epidemiologic reports. Given un-
certainty about the influence of factors such as changes in 
behavior (18), we focused our analysis on short-term fore-
casts and estimation of the number of beds required to turn 
over the epidemic. However, the epidemiologic landscape 
is changing rapidly, and the situation might have been dif-
ferent by late December/January, which would influence 
our specific estimates for bed requirements. In addition, 
transmission dynamics may vary by district, which would 
influence the precise number of beds required in different 
areas. Our results should therefore be viewed as qualita-
tive rather than quantitative. In addition, the reduction in 
transmission as a result of patients being in CCCs will, in 
reality, depend on several factors, including patient move-
ments, PPE effectiveness, infection control in the facility, 
and burial procedures (12), and these factors will likely 
differ between settings. Because it was not possible to es-
tablish the contribution of each factor to disease transmis-
sion without detailed data on the source of infection (8), we 
used a single parameter to capture the reduction in trans-
mission as a result of a patient being in a CCC. Given the 
uncertainty about the precise magnitude of this reduction, 
we assessed the effect of CCCs under the full range of po-
tential reductions in transmission, from no change to full 
containment, and conducted an elicitation of expert opin-
ions to identify plausible parameter ranges.
Furthermore, we assumed that infectiousness does not 
vary over the course of Ebola virus infection. However, if 
patients are most infectiousness during the final stages of in-
fection (19,20), then CCCs and ETCs would provide an even 
greater reduction in transmission because they would isolate 
patients when they are most infectious. In addition, it has 
been shown that it is not possible to reliably estimate mul-
tiple routes of transmission for Ebola virus from a single in-
cidence curve (8); thus, we chose to model community trans-
mission by using a single parameter, rather than attempting 
to estimate the contribution from living infected persons and 
from funerals. In the model, we also assumed that all patients 
seek health care. If in reality some do not, this will have the 
effect of increasing the average time from symptom onset to 
admission in a care center. A crucial point is that if patients 
on average spent more than half of their infectious periods in 
the community, then expansion of bed capacity alone would 
not be enough to turn over the epidemic in regions where the 
reproduction number is near 2.
 
Table. Parameters	used	in	a	transmission	model	for	evaluating	the	benefits	and	risks	of	introducing	CCCs	into	Western	Area,	 
Sierra	Leone* 
Parameter Value Source 
Mean	time	from	symptom	onset	to	outcome   
 Ebola	virus–positive	patients 9.5	d  (4) 
 Ebola	virus–negative	patients 7.0	d Assumed 
Mean	time	from	symptom	onset	to	admission   
 To ETC 4.6	d  (4) 
 To CCC 3.0	d Assumed 
Mean	time	from	exposure	to	symptom	onset	(latent	period) 9.4	d  (4) 
Proportion	of	patients	with	Ebola-like	symptoms	in	Western	Area	who	are	Ebola-positive 50.0%  (1) 
Population	of	Western	Area 1.4	million  (17) 
Probability	that	an	Ebola	virus–negative	patient	seeking	care	in	CCC	will	be	exposed	to	Ebola	
virus 
Varies† NA 
Reduction	in	transmission	from	infected	patients	to	the	community	as	a	result	of	being	in	CCC Varies† NA 
Basic	reproduction	no.	(95%	CrI)‡ 1.94	(1.86–1.98) Estimated 
No.	infectious	persons	on	August	16,	2014	(95%	CrI)§ 51	(39.0–57.0) Estimated 
Proportion	of	cases	in	Western	Area	reported	in	Sierra	Leone	Ministry	of	Health	situation	reports	
(95%	CrI) 
0.42	(0.33–0.46) Estimated 
Variability	in	accuracy	of	reports,	define	as	standard	deviation	of	proportion	of	cases	reported	
(95%	CrI) 
0.014	(0.010–0.024) Estimated 
*CCC,	Ebola	community	care	center;	CrI,	credible	interval;	ETC,	Ebola	treatment	center;	NA,	not	applicable. 
†In the analysis, the full range of possible values for these parameters is tested. 
‡Basic	reproduction	number	refers	to	the	average	number	of	secondary	cases	generated	by	a	typical	infectious	patient	at	the	start	of	an	epidemic 
§This	parameter	represents	the	initial	no.	of	infectious	patients	at	the	start	of	the	model	simulation.	Additional	information is	available	at	
https://drive.google.com/file/d/0B_BzCqSK1DZaYnRoeWtHOTU2TVk/. 
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In summary, CCCs may offer a rapid, high-coverage 
complement to ETCs and, thus, hold considerable potential 
for bringing about a sizeable shift in the epidemic pattern 
in Sierra Leone. The UK government is therefore support-
ing such a combined intervention in the Sierra Leone (7). 
However, the CCC approach is little tested in the field and 
could be harmful if infection control in CCCs is worse than 
that in the community or if Ebola virus–negative patients 
have a high risk of exposure to virus. Settings with limited 
triage, such as primary health care facilities, may also ex-
pose Ebola virus–negative patients to the virus and could 
therefore also have the potential to amplify the Ebola epi-
demic. Given the potential benefits and risks of introducing 
CCCs, real-time evaluation of their effectiveness must be 
carried out as they are implemented. In particular, to con-
firm the usefulness of CCCs as an epidemic control strate-
gy, estimates must be determined for the reduction in virus 
transmission as a result of infected patients being isolated 
in CCCs and for the probability of Ebola virus–negative 
patients being exposed to virus in CCCs.
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